Fennec Pharmaceuticals (FENC) logo

Fennec Pharmaceuticals (FENC) stock

Medicines for hearing loss , market cap $475M

After-hours Fri
$12.72
-2.83%

Close $13.09 -2.68%

Quality Score
13
Above Average
In its industry
#16of 273
Checks firing
5of 14
Trending up
From 52-week high
-5.5%
under its best in a year
See FENC's 14 chart checksSee FENC's 14 chart checksSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why FENC rose 33% since Nov 6

Up 33% from Nov 6 to Nov 20 while the S&P 500 fell 6%.

  • Fennec Pharmaceuticals rose 33% from Nov 6 to Nov 20 while biotech stocks fell a median 9%: it beat its group by 42 points.

Sources: Price history, Nov 20, 2026

Key facts on FENC

Key facts on FENC
The companySales up 71% on the year
Latest filing10-Q, Nov 12 Filed its quarterly report (10-Q) for the quarter to Sep 30, 2026

FENC catalysts

Coming up

After its last 4 reports it closed +10.9% on average, higher 4 of 4 times.

Why FENC scores 13

Above Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means

Well above its recent run. FENC scores 13 today, against a median of 7 over its last 20 recorded sessions.

  • +5Chart checks 5 of 14 firing right now, one point each
  • +4Long-term trend above a rising 200-⁠day average, near its 52-⁠week high, at a multi-⁠year high
  • Run-up adds
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • Dilution subtractsNew shares over the year: -1 at 10% more, -2 at 25% more.

No effect today: Size, Volatility, Cash flow, Persistence, News, and Insider trades.

What every line is worth, and the reason behind it, on FENC and every other stock.Get in free →See the top 3 →Start Pro

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:50 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when FENC's Quality Score turns up

A free account. No card.Pro: $1 first month.Pro, 7 days free with a card.

How FENC ranks in Biotech

FENC is #16 of 273 by Quality Score.

How FENC ranks in Biotech
RankStockQuality Score
16Fennec Pharmaceuticals (FENC) logoFENCFennec Pharmaceuticals13

More in Biotech

When does FENC report earnings, and what happens after?

Expected to report Tue Mar 23, before the open (in 122 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

Close after the report, last 3

+2.5%+36.5%+2.4%
Mar 24May 14Nov 12
ReportedGapReaction5
days
Nov 12, 2026Before open+0.8%+2.4%+25.3%
May 14, 2026Before open+6.3%+36.5%+44.0%
Mar 24, 2026After close-1.5%+2.5%+2.2%

FENC closed higher after 4 of its last 4 reports.

All 4 reports, and FENC's Quality Score going into each

FENC sales and profit by year

Sales and profit by year

Sales grew in three of the last six years, to $44.6M in 2025. It lost money in each of the eight years.

FENC has 5 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on FENC, and all 14 on every stock.Get in free →See the top 3 →Start Pro

FENC RSI on Nov 20: 66.0, above its 50-day and 200-day averages

Not scored

RSI 66.0, MACD above signal, above both averages. Not scored.

The deep dive on FENC

  • What it does and how it makes money6 findingsAn operating loss of $6.28M in fiscal 2025, on $44.6M of sales.Annual report, filed Mar 27, 2026"The US ‘728, US ‘984, US ‘793, US ‘018, US ‘530, and US ‘604 Patents will expire in 2039." (10-K for fiscal 2025)SEC filing · Mar 27, 2026
  • Where it stands5 findingsFor Pro members5 findings on where FENC stands: its cash, debt, and share count, for Pro members
  • What changed in its filings5 findings"On July 30, 2024, the court granted us leave to file the Third Amended Complaint, which we filed on September 16, 2024." (10-K for fiscal 2025)SEC filing · Mar 27, 2026A new heading in its "Risk Factors" this year: "Geopolitical instability and armed conflicts in Turkey and the Middle East could disrupt our product distribution and sales and adversely affect our business. We depend on third-party logistics providers, distributors, and healthcare systems to store, transport, and dispense our products in Turkey and the broader Middle East region." (10-K for fiscal 2025; not in fiscal 2024's)SEC filing · Mar 27, 2026, against the one of Mar 26, 2025
  • Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades FENC, for Pro members

14 more findings on FENC, each with its source, for Pro members.

FENC share count over time

Shares: 25.9% more than a year ago (to Sep 30).

Shares of FENC outstanding, as filed
Shares
outstanding
As
of
35.3MNov 10, 2026
35.1MAug 11, 2026
34.7MMay 12, 2026
34.5MMar 20, 2026
Offerings, shelves, and splits of FENC, from its filings
From its
filings
Filed
Priced a sale of sharesNov 18, 2025

FENC insider trades

One insider sold $146K across 1 filing in the last 6 months. No open-⁠market buys on record. The newest:

SellPierre Sargis Sayad$146KChief Medical Officerat $12.18 on Aug 31, filed Aug 31

FENC's officers and directors

Officers and directors with a Form 4 in the last 12 months.

See insider trades by person

Which ETFs hold FENC?

In ETFs: FENC is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

35 employeesResearch Triangle Park, NCfennecpharma.com

What Fennec Pharmaceuticals says it competes with

“The biotechnology and pharmaceutical industries are extremely competitive.”

From its annual report, SEC filing · Mar 27, 2026

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on FENC and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would move FENC's score: 4 things
  • 2 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayAug 31Pierre Sargis Sayad sold FENC$146K at $12.18, filed Aug 31

Alerts are optional.

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 21, 2026: FENC's Quality Score is 13 (Above Average), #16 of 273 in Biotech. Insiders sold $146K in the last 6 months (Form 4).

What does FENC's Quality Score say?

FENC scores 13 today, which Breakaway calls Above Average. It is #16 of 273 in Biotech by Quality Score, with 5 of 14 chart checks firing. Up 33% from Nov 6 to Nov 20 while the S&P 500 fell 6%. Shares: 25.9% more than a year ago (to Sep 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is FENC's Quality Score?

FENC scores 13 today, which Breakaway calls Above Average (11 to 14). That is #16 of 273 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind FENC's 13.

Are insiders buying FENC?

One insider sold $146K across 1 filing in the last 6 months. No open-⁠market buys on record. The newest is Pierre Sargis Sayad, Chief Medical Officer, who sold $146K on Aug 31.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,170 stocks rankedSee all 3,170 stocks rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.